Seeing Is Believing
ATXS is currently covered by 3 analysts with an average price target of $17.35. This is a potential upside of $8.35 (92.78%) from yesterday's end of day stock price of $9.
Astria Therapeutics's activity chart (see below) currently has 17 price targets and 26 ratings on display. The stock rating distribution of ATXS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 41.8% with an average time for these price targets to be met of 187.17 days.
Highest price target for ATXS is $22, Lowest price target is $16, average price target is $17.35.
Most recent stock forecast was given by JOSEPH PANTGINIS from HC WAINWRIGHT on 23-Apr-2024. First documented stock forecast 14-Jan-2019.
Currently out of the existing stock ratings of ATXS, 14 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
16
$7 (77.78%)
18
3 days ago
2/9 (22.22%)
$6.36 (65.98%)
255
Buy
22
$13 (144.44%)
17
1 months ago
2/7 (28.57%)
$8.47 (62.60%)
674
Buy
30
5 months 11 days ago
0/4 (0%)
$18.4 (158.62%)
Buy
6
$-0.12 (-1.96%)
2 years 5 months 14 days ago
1/1 (100%)
$-1.33 (-18.14%)
19
Buy
20
$12.54 (168.10%)
2 years 6 months 25 days ago
0/1 (0%)
$11.38 (132.02%)
What is ATXS (Astria Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ATXS (Astria Therapeutics) with a proven track record?
Which analyst has the current lower performing score on ATXS (Astria Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ATXS (Astria Therapeutics)?
Which analyst is the currently most bullish on ATXS (Astria Therapeutics)?
Which analyst is the currently most reserved on ATXS (Astria Therapeutics)?